Loading…

Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte‐colony stimulating factor

Summary Background Defective neutrophil recruitment has been described as a primary pathogenic abnormality in Crohn’s disease. Cantharidin‐induced blisters provide a novel investigative tool to assess cellular influx and inflammatory mediator production during acute inflammation and allows the effec...

Full description

Saved in:
Bibliographic Details
Published in:Alimentary pharmacology & therapeutics 2006-08, Vol.24 (4), p.651-660
Main Authors: HARBORD, M. W. N., MARKS, D. J. B., FORBES, A., BLOOM, S. L., DAY, R. M., SEGAL, A. W.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5336-752fb55a4985997db3338a2a33413a6b62b3a8286166043e4b35d6eaebf053e43
cites cdi_FETCH-LOGICAL-c5336-752fb55a4985997db3338a2a33413a6b62b3a8286166043e4b35d6eaebf053e43
container_end_page 660
container_issue 4
container_start_page 651
container_title Alimentary pharmacology & therapeutics
container_volume 24
creator HARBORD, M. W. N.
MARKS, D. J. B.
FORBES, A.
BLOOM, S. L.
DAY, R. M.
SEGAL, A. W.
description Summary Background Defective neutrophil recruitment has been described as a primary pathogenic abnormality in Crohn’s disease. Cantharidin‐induced blisters provide a novel investigative tool to assess cellular influx and inflammatory mediator production during acute inflammation and allows the effects of therapy on these parameters to be measured. Aims To determine whether reduced neutrophil tissue penetration in Crohn's disease relates to impaired production of inflammatory mediators, and whether it can be reversed by granulocyte‐colony stimulating factor (G‐CSF). Methods Neutrophil and monocyte/macrophage populations and inflammatory mediators were measured in cantharidin blisters at 24 h. Neutrophil chemotaxis was assessed in vitro using blister fluid as the chemoattractant. The effect of s.c. G‐CSF on blister phenotype was determined. Results Significantly fewer neutrophils migrated into blisters in Crohn's patients. The production of neutrophil chemokines, but not other inflammatory mediators, was reduced. This significantly correlated with reduced chemotaxis in vitro. Differences were unrelated to caspase‐recruitment domain 15 genotype. G‐CSF significantly increased blister neutrophil concentrations in control subjects and Crohn's patients. Conclusions Reduced neutrophil migration during acute inflammation in Crohn's disease is associated with impaired production of appropriate chemoattractants. G‐CSF therapy increases neutrophil tissue migration, which may partially account for its observed therapeutic effect.
doi_str_mv 10.1111/j.1365-2036.2006.03016.x
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2648502</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68743715</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5336-752fb55a4985997db3338a2a33413a6b62b3a8286166043e4b35d6eaebf053e43</originalsourceid><addsrcrecordid>eNqNkk2O1DAQhS0EYpqGKyBvgFWCfxInWYA0ajEw0kiwGNZWxXG63SR2sJOhs-MIcwEux0lw6NYMrMAbl-XvPVXpFUKYkpTG83qfUi7yhBEuUkaISAknVKSHB2h19_EQrQgTVcJKys_QkxD2JJIFYY_RGRUVKcqqXKEfl_0AxusGWz2N3g0702G1070b4WACNhZvvNvZVwE3JmgIGnvdwagDHl0sm0lF7eBdLEbjLHbtUf7F2MiAbbACi2uNYdr22o6Rrme89WCnzql51D-_3yrXOTvjMJp-it7GbnELanT-KXrUQhf0s9O9Rp8v3l1vPiRXH99fbs6vEpVzLpIiZ22d55BVZV5VRVNzzktgwHlGOYhasJpDyUpBhSAZ11nN80Zo0HVL8vjka_T26DtMda8bFfv00MnBmx78LB0Y-fePNTu5dTeSiazMCYsGL08G3n2ddBhlb4LSXQdWuylIURYZL2j-T5BWWcYXeI3KI6i8C8Hr9q4bSuSyBHIvl6zlkrVclkD-XgJ5iNLnf05zLzylHoEXJwCCgq6NYSgT7rmiqihny1Rvjtw30-n5vxuQ55-ul4r_AvKm0n0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19443874</pqid></control><display><type>article</type><title>Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte‐colony stimulating factor</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>HARBORD, M. W. N. ; MARKS, D. J. B. ; FORBES, A. ; BLOOM, S. L. ; DAY, R. M. ; SEGAL, A. W.</creator><creatorcontrib>HARBORD, M. W. N. ; MARKS, D. J. B. ; FORBES, A. ; BLOOM, S. L. ; DAY, R. M. ; SEGAL, A. W.</creatorcontrib><description>Summary Background Defective neutrophil recruitment has been described as a primary pathogenic abnormality in Crohn’s disease. Cantharidin‐induced blisters provide a novel investigative tool to assess cellular influx and inflammatory mediator production during acute inflammation and allows the effects of therapy on these parameters to be measured. Aims To determine whether reduced neutrophil tissue penetration in Crohn's disease relates to impaired production of inflammatory mediators, and whether it can be reversed by granulocyte‐colony stimulating factor (G‐CSF). Methods Neutrophil and monocyte/macrophage populations and inflammatory mediators were measured in cantharidin blisters at 24 h. Neutrophil chemotaxis was assessed in vitro using blister fluid as the chemoattractant. The effect of s.c. G‐CSF on blister phenotype was determined. Results Significantly fewer neutrophils migrated into blisters in Crohn's patients. The production of neutrophil chemokines, but not other inflammatory mediators, was reduced. This significantly correlated with reduced chemotaxis in vitro. Differences were unrelated to caspase‐recruitment domain 15 genotype. G‐CSF significantly increased blister neutrophil concentrations in control subjects and Crohn's patients. Conclusions Reduced neutrophil migration during acute inflammation in Crohn's disease is associated with impaired production of appropriate chemoattractants. G‐CSF therapy increases neutrophil tissue migration, which may partially account for its observed therapeutic effect.</description><identifier>ISSN: 0269-2813</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1111/j.1365-2036.2006.03016.x</identifier><identifier>PMID: 16907898</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Aged ; Biological and medical sciences ; Chemokines - metabolism ; Chemotaxis, Leukocyte - physiology ; Crohn Disease - drug therapy ; Crohn Disease - immunology ; Crohn Disease - metabolism ; Digestive system ; Female ; Gastroenterology. Liver. Pancreas. Abdomen ; Granulocyte Colony-Stimulating Factor - therapeutic use ; Humans ; Male ; Medical sciences ; Middle Aged ; Neutrophils - physiology ; Other diseases. Semiology ; Pharmacology. Drug treatments ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><ispartof>Alimentary pharmacology &amp; therapeutics, 2006-08, Vol.24 (4), p.651-660</ispartof><rights>2006 INIST-CNRS</rights><rights>2006 Blackwell Publishing Ltd 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5336-752fb55a4985997db3338a2a33413a6b62b3a8286166043e4b35d6eaebf053e43</citedby><cites>FETCH-LOGICAL-c5336-752fb55a4985997db3338a2a33413a6b62b3a8286166043e4b35d6eaebf053e43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17991322$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16907898$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HARBORD, M. W. N.</creatorcontrib><creatorcontrib>MARKS, D. J. B.</creatorcontrib><creatorcontrib>FORBES, A.</creatorcontrib><creatorcontrib>BLOOM, S. L.</creatorcontrib><creatorcontrib>DAY, R. M.</creatorcontrib><creatorcontrib>SEGAL, A. W.</creatorcontrib><title>Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte‐colony stimulating factor</title><title>Alimentary pharmacology &amp; therapeutics</title><addtitle>Aliment Pharmacol Ther</addtitle><description>Summary Background Defective neutrophil recruitment has been described as a primary pathogenic abnormality in Crohn’s disease. Cantharidin‐induced blisters provide a novel investigative tool to assess cellular influx and inflammatory mediator production during acute inflammation and allows the effects of therapy on these parameters to be measured. Aims To determine whether reduced neutrophil tissue penetration in Crohn's disease relates to impaired production of inflammatory mediators, and whether it can be reversed by granulocyte‐colony stimulating factor (G‐CSF). Methods Neutrophil and monocyte/macrophage populations and inflammatory mediators were measured in cantharidin blisters at 24 h. Neutrophil chemotaxis was assessed in vitro using blister fluid as the chemoattractant. The effect of s.c. G‐CSF on blister phenotype was determined. Results Significantly fewer neutrophils migrated into blisters in Crohn's patients. The production of neutrophil chemokines, but not other inflammatory mediators, was reduced. This significantly correlated with reduced chemotaxis in vitro. Differences were unrelated to caspase‐recruitment domain 15 genotype. G‐CSF significantly increased blister neutrophil concentrations in control subjects and Crohn's patients. Conclusions Reduced neutrophil migration during acute inflammation in Crohn's disease is associated with impaired production of appropriate chemoattractants. G‐CSF therapy increases neutrophil tissue migration, which may partially account for its observed therapeutic effect.</description><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Chemokines - metabolism</subject><subject>Chemotaxis, Leukocyte - physiology</subject><subject>Crohn Disease - drug therapy</subject><subject>Crohn Disease - immunology</subject><subject>Crohn Disease - metabolism</subject><subject>Digestive system</subject><subject>Female</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Granulocyte Colony-Stimulating Factor - therapeutic use</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neutrophils - physiology</subject><subject>Other diseases. Semiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><issn>0269-2813</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqNkk2O1DAQhS0EYpqGKyBvgFWCfxInWYA0ajEw0kiwGNZWxXG63SR2sJOhs-MIcwEux0lw6NYMrMAbl-XvPVXpFUKYkpTG83qfUi7yhBEuUkaISAknVKSHB2h19_EQrQgTVcJKys_QkxD2JJIFYY_RGRUVKcqqXKEfl_0AxusGWz2N3g0702G1070b4WACNhZvvNvZVwE3JmgIGnvdwagDHl0sm0lF7eBdLEbjLHbtUf7F2MiAbbACi2uNYdr22o6Rrme89WCnzql51D-_3yrXOTvjMJp-it7GbnELanT-KXrUQhf0s9O9Rp8v3l1vPiRXH99fbs6vEpVzLpIiZ22d55BVZV5VRVNzzktgwHlGOYhasJpDyUpBhSAZ11nN80Zo0HVL8vjka_T26DtMda8bFfv00MnBmx78LB0Y-fePNTu5dTeSiazMCYsGL08G3n2ddBhlb4LSXQdWuylIURYZL2j-T5BWWcYXeI3KI6i8C8Hr9q4bSuSyBHIvl6zlkrVclkD-XgJ5iNLnf05zLzylHoEXJwCCgq6NYSgT7rmiqihny1Rvjtw30-n5vxuQ55-ul4r_AvKm0n0</recordid><startdate>20060815</startdate><enddate>20060815</enddate><creator>HARBORD, M. W. N.</creator><creator>MARKS, D. J. B.</creator><creator>FORBES, A.</creator><creator>BLOOM, S. L.</creator><creator>DAY, R. M.</creator><creator>SEGAL, A. W.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QR</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20060815</creationdate><title>Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte‐colony stimulating factor</title><author>HARBORD, M. W. N. ; MARKS, D. J. B. ; FORBES, A. ; BLOOM, S. L. ; DAY, R. M. ; SEGAL, A. W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5336-752fb55a4985997db3338a2a33413a6b62b3a8286166043e4b35d6eaebf053e43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Chemokines - metabolism</topic><topic>Chemotaxis, Leukocyte - physiology</topic><topic>Crohn Disease - drug therapy</topic><topic>Crohn Disease - immunology</topic><topic>Crohn Disease - metabolism</topic><topic>Digestive system</topic><topic>Female</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Granulocyte Colony-Stimulating Factor - therapeutic use</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neutrophils - physiology</topic><topic>Other diseases. Semiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HARBORD, M. W. N.</creatorcontrib><creatorcontrib>MARKS, D. J. B.</creatorcontrib><creatorcontrib>FORBES, A.</creatorcontrib><creatorcontrib>BLOOM, S. L.</creatorcontrib><creatorcontrib>DAY, R. M.</creatorcontrib><creatorcontrib>SEGAL, A. W.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Chemoreception Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HARBORD, M. W. N.</au><au>MARKS, D. J. B.</au><au>FORBES, A.</au><au>BLOOM, S. L.</au><au>DAY, R. M.</au><au>SEGAL, A. W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte‐colony stimulating factor</atitle><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle><addtitle>Aliment Pharmacol Ther</addtitle><date>2006-08-15</date><risdate>2006</risdate><volume>24</volume><issue>4</issue><spage>651</spage><epage>660</epage><pages>651-660</pages><issn>0269-2813</issn><eissn>1365-2036</eissn><abstract>Summary Background Defective neutrophil recruitment has been described as a primary pathogenic abnormality in Crohn’s disease. Cantharidin‐induced blisters provide a novel investigative tool to assess cellular influx and inflammatory mediator production during acute inflammation and allows the effects of therapy on these parameters to be measured. Aims To determine whether reduced neutrophil tissue penetration in Crohn's disease relates to impaired production of inflammatory mediators, and whether it can be reversed by granulocyte‐colony stimulating factor (G‐CSF). Methods Neutrophil and monocyte/macrophage populations and inflammatory mediators were measured in cantharidin blisters at 24 h. Neutrophil chemotaxis was assessed in vitro using blister fluid as the chemoattractant. The effect of s.c. G‐CSF on blister phenotype was determined. Results Significantly fewer neutrophils migrated into blisters in Crohn's patients. The production of neutrophil chemokines, but not other inflammatory mediators, was reduced. This significantly correlated with reduced chemotaxis in vitro. Differences were unrelated to caspase‐recruitment domain 15 genotype. G‐CSF significantly increased blister neutrophil concentrations in control subjects and Crohn's patients. Conclusions Reduced neutrophil migration during acute inflammation in Crohn's disease is associated with impaired production of appropriate chemoattractants. G‐CSF therapy increases neutrophil tissue migration, which may partially account for its observed therapeutic effect.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>16907898</pmid><doi>10.1111/j.1365-2036.2006.03016.x</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0269-2813
ispartof Alimentary pharmacology & therapeutics, 2006-08, Vol.24 (4), p.651-660
issn 0269-2813
1365-2036
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2648502
source Wiley-Blackwell Read & Publish Collection
subjects Adult
Aged
Biological and medical sciences
Chemokines - metabolism
Chemotaxis, Leukocyte - physiology
Crohn Disease - drug therapy
Crohn Disease - immunology
Crohn Disease - metabolism
Digestive system
Female
Gastroenterology. Liver. Pancreas. Abdomen
Granulocyte Colony-Stimulating Factor - therapeutic use
Humans
Male
Medical sciences
Middle Aged
Neutrophils - physiology
Other diseases. Semiology
Pharmacology. Drug treatments
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
title Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte‐colony stimulating factor
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A48%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impaired%20neutrophil%20chemotaxis%20in%20Crohn's%20disease%20relates%20to%20reduced%20production%20of%20chemokines%20and%20can%20be%20augmented%20by%20granulocyte%E2%80%90colony%20stimulating%20factor&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=HARBORD,%20M.%20W.%20N.&rft.date=2006-08-15&rft.volume=24&rft.issue=4&rft.spage=651&rft.epage=660&rft.pages=651-660&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1111/j.1365-2036.2006.03016.x&rft_dat=%3Cproquest_pubme%3E68743715%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5336-752fb55a4985997db3338a2a33413a6b62b3a8286166043e4b35d6eaebf053e43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19443874&rft_id=info:pmid/16907898&rfr_iscdi=true